These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 15746568

  • 1. Comparison of in vitro susceptibilities of ocular bacterial isolates to gatifloxacin and other topical antibiotics.
    Kaliamurthy J, Nelson Jesudasan CA, Geraldine P, Parmar P, Kalavathy CM, Thomas PA.
    Ophthalmic Res; 2005; 37(3):117-22. PubMed ID: 15746568
    [Abstract] [Full Text] [Related]

  • 2. [In vitro fluoroquinolone resistance in ocular bacterial isolates].
    Sun XG, Wang ZQ, Li R, Chen L, Jin XY, Luo SY.
    Zhonghua Yan Ke Za Zhi; 2003 Mar; 39(3):163-6. PubMed ID: 12880574
    [Abstract] [Full Text] [Related]

  • 3. Activity of newer fluoroquinolones against gram-positive and gram-negative bacteria isolated from ocular infections: an in vitro comparison.
    Duggirala A, Joseph J, Sharma S, Nutheti R, Garg P, Das T.
    Indian J Ophthalmol; 2007 Mar; 55(1):15-9. PubMed ID: 17189881
    [Abstract] [Full Text] [Related]

  • 4. In vitro antibiotic susceptibilities of ocular isolates in North and South America. In Vitro Antibiotic Testing Group.
    Jensen HG, Felix C.
    Cornea; 1998 Jan; 17(1):79-87. PubMed ID: 9436885
    [Abstract] [Full Text] [Related]

  • 5. In vitro activity of fluoroquinolones against ocular bacterial isolates in São Paulo, Brazil.
    Oliveira AD, D'Azevedo PA, Francisco W.
    Cornea; 2007 Feb; 26(2):194-8. PubMed ID: 17251812
    [Abstract] [Full Text] [Related]

  • 6. Comparison of in vitro susceptibilities of Gram-positive cocci isolated from ocular infections against the second and fourth generation quinolones at a tertiary eye care centre in South India.
    Reddy AK, Garg P, Alam MR, Gopinathan U, Sharma S, Krishnaiah S.
    Eye (Lond); 2010 Jan; 24(1):170-4. PubMed ID: 19229279
    [Abstract] [Full Text] [Related]

  • 7. [Antibiotic susceptibility patterns of bacteria isolated from keratitis and intraocular infections at Fundación Oftalmológica de Santander (FOSCAL), Floridablanca, Colombia].
    Galvis V, Tello A, Guerra A, Acuña MF, Villarreal D.
    Biomedica; 2014 Apr; 34 Suppl 1():23-33. PubMed ID: 24968033
    [Abstract] [Full Text] [Related]

  • 8. [In vitro antibiotic susceptibility to fluoroquinolones].
    Wong CA, Galvis V, Tello A, Villareal D, Rey JJ.
    Arch Soc Esp Oftalmol; 2012 Mar; 87(3):72-8. PubMed ID: 22423655
    [Abstract] [Full Text] [Related]

  • 9. In vitro susceptibilities to topical antibiotics of bacteria isolated from the surface of clinically symptomatic eyes.
    Egger SF, Ruckhofer J, Alzner E, Hell M, Hitzl W, Huber-Spitzy V, Grabner G.
    Ophthalmic Res; 2001 Mar; 33(2):117-20. PubMed ID: 11244359
    [Abstract] [Full Text] [Related]

  • 10. Review of third-and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacy.
    Scoper SV.
    Adv Ther; 2008 Oct; 25(10):979-94. PubMed ID: 18836691
    [Abstract] [Full Text] [Related]

  • 11. Surveillance of the susceptibility of ocular bacterial pathogens to the fluoroquinolone gatifloxacin and other antimicrobials in Europe during 2001/2002.
    Morrissey I, Burnett R, Viljoen L, Robbins M.
    J Infect; 2004 Aug; 49(2):109-14. PubMed ID: 15236917
    [Abstract] [Full Text] [Related]

  • 12. Emergence of resistance to fluoroquinolones among gram positive and gram negative clinical isolates.
    Nesar S, Shoaib MH, Rahim N, Rehman R.
    Pak J Pharm Sci; 2012 Oct; 25(4):877-81. PubMed ID: 23010009
    [Abstract] [Full Text] [Related]

  • 13. The resistance patterns of normal ocular bacterial flora to 4 fluoroquinolone antibiotics.
    Park SH, Lim JA, Choi JS, Kim KA, Joo CK.
    Cornea; 2009 Jan; 28(1):68-72. PubMed ID: 19092409
    [Abstract] [Full Text] [Related]

  • 14. An in vitro comparison of the susceptibilities of bacterial isolates from patients with conjunctivitis and blepharitis to newer and established topical antibiotics.
    Everett SL, Kowalski RP, Karenchak LM, Landsittel D, Day R, Gordon YJ.
    Cornea; 1995 Jul; 14(4):382-7. PubMed ID: 7671609
    [Abstract] [Full Text] [Related]

  • 15. [Analysis on susceptibility of ocular bacterial pathogens to four kinds of fluoroquinolone].
    Wang ZQ, Li L, Li R, Luo SY, Bai XQ, Liang QF, Deng SJ, Sun XG.
    Zhonghua Yan Ke Za Zhi; 2008 Mar; 44(3):233-6. PubMed ID: 18785547
    [Abstract] [Full Text] [Related]

  • 16. In vitro susceptibility of bacterial keratitis isolates to fourth-generation fluoroquinolones.
    Chawla B, Agarwal P, Tandon R, Titiyal JS, Sharma N, Agarwal T, Navak N, Satpathy G.
    Eur J Ophthalmol; 2010 Mar; 20(2):300-5. PubMed ID: 19924668
    [Abstract] [Full Text] [Related]

  • 17. Spectrum of aetiological agents of postoperative endophthalmitis and antibiotic susceptibility of bacterial isolates.
    Anand AR, Therese KL, Madhavan HN.
    Indian J Ophthalmol; 2000 Jun; 48(2):123-8. PubMed ID: 11116508
    [Abstract] [Full Text] [Related]

  • 18. Activity of nadifloxacin (OPC-7251) and seven other antimicrobial agents against aerobic and anaerobic Gram-positive bacteria isolated from bacterial skin infections.
    Nenoff P, Haustein UF, Hittel N.
    Chemotherapy; 2004 Oct; 50(4):196-201. PubMed ID: 15452398
    [Abstract] [Full Text] [Related]

  • 19. Antimicrobial activity of fluoroquinolones and other antibiotics on 1,116 clinical gram-positive and gram-negative isolates.
    Mascellino MT, Farinelli S, Iegri F, Iona E, De Simone C.
    Drugs Exp Clin Res; 1998 Oct; 24(3):139-51. PubMed ID: 9825230
    [Abstract] [Full Text] [Related]

  • 20. Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003).
    Sader HS, Fritsche TR, Jones RN.
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):265-73. PubMed ID: 16105569
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.